Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment.
Giulia SitaRaffaella ArfèAgnese GraziosiFabiana MorroniPublished in: Nutrients (2018)
Sulforaphane (SFN), an isothiocyanate (ITC) derived from cruciferous vegetables, particularly broccoli and broccoli sprouts, has been widely investigated due to its promising health-promoting properties in disease, and low toxicity in normal tissue. Although not yet fully understood, many mechanisms of anticancer activity at each step of cancer development have been attributed to this ITC. Given the promising data available regarding SFN, this review aimed to provide an overview on the potential activities of SFN related to the cellular mechanisms involved in glioblastoma (GBM) progression. GBM is the most frequent malignant brain tumor among adults and is currently an incurable disease due mostly to its highly invasive phenotype, and the poor efficacy of the available therapies. Despite all efforts, the median overall survival of GBM patients remains approximately 1.5 years under therapy. Therefore, there is an urgent need to provide support for translating the progress in understanding the molecular background of GBM into more complex, but promising therapeutic strategies, in which SFN may find a leading role.
Keyphrases
- human health
- end stage renal disease
- ejection fraction
- healthcare
- newly diagnosed
- public health
- mental health
- health risk
- papillary thyroid
- prognostic factors
- electronic health record
- health information
- quality improvement
- squamous cell carcinoma
- machine learning
- heavy metals
- health risk assessment
- mass spectrometry
- atomic force microscopy
- patient reported outcomes
- mesenchymal stem cells
- social media
- cell therapy
- high resolution
- high speed
- smoking cessation